Conventional methods for determining drug susceptibility of Mycobacterium tuberculosis require several weeks to obtain results, limiting their usefulness; automated methods and those based on molecular biology techniques have been able to reduce the turnaround time, but their high cost and need for sophisticated equipment restrict their use in developing countries. The goal of the present study was to evaluate the diagnostic accuracy of a rapid (3–4 days) low-cost test based on the use of mycobacteriophage D29 to determine the susceptibility of strains of M. tuberculosis to rifampicin (RIF) and isoniazid (INH). Results obtained show that susceptibility testing for RIF has a high diagnostic accuracy as compared to the standard indirect proportion method on Löwenstein–Jensen medium (sensitivity 100 % and specificity 98 %). Given the association between the resistance to RIF and INH, which define multidrug resistance (MDR), this test seems suitable for rapid detection of MDR tuberculosis strains (κ=0.978). Susceptibility testing for INH using mycobacteriophage D29 had a good but lower diagnostic accuracy as compared to the standard method (sensitivity 80.4 % and specificity 80.8 %); the test would then be of limited usefulness in the management of tuberculosis patients. Further studies to determine the relationship of mycobacteriophage D29 tests to in vivo correlates of sensitivity to specific antituberculosis drugs are warranted.
AltmanD.1991; Some common problems in medical research. In Practical Statistics for Medical Research pp 396–439 Edited by
AltmanD. G.
London: Chapman & Hall;
BardouF.,
QuémardA.,
DupontM.,
HornC.,
MarchalG.,
DafféM.1996; Effects of isoniazid on ultrastructure of Mycobacterium aurum and Mycobacterium tuberculosis and on production of secreted proteins. Antimicrob Agents Chemother 40:2459–2467
DavidH.,
ClavelS.,
ClementF.1980a; Adsorption and growth of the bacteriophage D29 in selected mycobacteria. Ann Virol (Inst Pasteur 131:167–184[CrossRef]
EltringhamI.,
DrobniewskiF. A.,
ManganJ. A.,
ButcherP. D.,
WilsonS. M.1999a; Evaluation of reverse transcription-PCR and a bacteriophage-based assay for rapid phenotypic detection of rifampin resistance in clinical isolates of Mycobacterium tuberculosis
. J Clin Microbiol 37:3524–3527
EltringhamI.,
WilsonS.,
DrobniewskiF.1999b; Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis
. J Clin Microbiol 37:3528–3532
GalíN.,
DomínguezJ.,
BlancoS.,
PratC.,
AlcaideF.,
CollP.,
AusinaV.2006; Use of a mycobacteriophage-based assay for rapid assessment of susceptibilities of Mycobacterium tuberculosis isolates to isoniazid and influence of resistance level on assay performance. J Clin Microbiol 44:201–205[CrossRef]
HatfullG.2005; Mycobacteriophages: pathogenesis and applications.. In Phages: Their Role in Bacterial Pathogenesis and Biotechnology pp 238–255 Edited by
WaldorM.,
FriedmanD.,
AdhyaS.
Washington, DC: American Society for Microbiology;
HeifetsL.
editor 1991; Drug susceptibility test in the management of chemotherapy of tuberculosis. In Drug Susceptibility in the Chemotherapy of Mycobacterial Infections pp 90–115 Florida: CRC Press;
HeifetsL.,
CangelosiG.1999; Drug susceptibility testing of Mycobacterium tuberculosis : a neglected problem at the turn of the century. Int J Tuberc Lung Dis 3:564–581
IsemanM. D.1998; MDR-TB and the developing world – a problem no longer to be ignored: the WHO announces ‘DOTS Plus' strategy. Int J Tuberc Lung Dis 2:867
KentP. T.,
KubicaG. P.1985Public Health Mycobacteriology: a Guide for the Level III Laboratory Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control;
McNerneyR.,
WilsonS.,
SidhuA.,
HarleyV.,
Al-SuwanidiZ.,
NyeP.,
ParishT.,
StokerN.1998; Inactivation of mycobacteriophage D29 using ferrous ammonium sulphate as a tool for the detection of viable Mycobacterium smegmatis and M. tuberculosis
. Res Microbiol 149:487–495[CrossRef]
McNerneyR.,
KiepielaP.,
BishopK.,
NyeP. M.,
StokerN. G.2000; Rapid screening of Mycobacterium tuberculosis for susceptibility to rifampicin and streptomycin. Int J Tuberc Lung Dis 4:69–75
TortoliE.,
BenedettiM.,
FontanelliA.,
SimonettiM.2002; Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion. J Clin Microbiol 40:607–610[CrossRef]
WattersonS.,
WilsonS.,
YatesW.,
DrobniewskiF.1998; Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis
. J Clin Microbiol 36:1969–1973
WilsonS.,
Al-SuwaidiZ.,
McNerneyR.,
PorterJ.,
DrobniewskiF.1997; Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis
. Nat Med 34:465–468
World Health Organization1997Global Tuberculosis Programme. Anti-Tuberculosis Drug Resistance in the World. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance 1994–1997. Annex 2 – Individual Country Profiles . WHO/TB/97.229 Geneva: World Health Organization;
World Health Organization2005WHO Report 2005. Global Tuberculosis Control – Surveillance, Planning, Financing . WHO/HTM/TB/2005.349 Geneva: World Health Organization;